Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
1.250
-0.080 (-6.02%)
At close: Feb 21, 2025, 4:00 PM
1.220
-0.030 (-2.40%)
After-hours: Feb 21, 2025, 7:53 PM EST
Kairos Pharma Market Cap
Kairos Pharma has a market cap or net worth of $16.32 million as of February 21, 2025.
Market Cap
16.32M
Enterprise Value
13.24M
1-Year Change
n/a
Ranking
Category
Stock Price
$1.25
Market Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $33.39M to $16.32M, a decrease of -51.14%. That is a compound annual growth rate of -81.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 17.09M | -12.50% |
| Dec 31, 2024 | 19.53M | -41.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 781.79B |
| UnitedHealth Group | 463.20B |
| Johnson & Johnson | 379.92B |
| Novo Nordisk | 365.53B |
| AbbVie | 348.85B |
| AstraZeneca | 230.61B |
| Abbott Laboratories | 229.03B |
| Intuitive Surgical | 216.39B |